Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis

Paolo Gelosa, Gulnur Sevin, Alice Pignieri, Silvia Budelli, Laura Castiglioni, Vanessa Blanc-Guillemaud, Laurence Lerond, Elena Tremoli, Luigi Sironi

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Thromboxane A 2 and other eicosanoids such as isoprostanes contribute to vascular proliferation and atherosclerosis by binding to the thromboxane/prostaglandin endoperoxide receptors. The effects of terutroban, a thromboxane/ prostaglandin endoperoxide receptor antagonist, on aorta remodeling were evaluated in spontaneously hypertensive stroke-prone rats (SHRSPs), a model of severe hypertension, endothelial dysfunction, vascular inflammation, and cerebrovascular diseases. Male SHRSPs were allocated to three groups receiving a standard diet (n = 5) or a high-sodium permissive diet plus vehicle (n = 6) or plus terutroban (30 mg·kg -1·day -1; n = 6). After 6 wk of dietary treatment, all of the animals were injected with bromodeoxyuridine and simultaneously euthanized for aorta collection. The aortic media thickness-to-lumen ratio significantly (P <0.0001) increased in the salt-loaded rats compared with the rats fed a standard diet, whereas terutroban treatment completely prevented media thickening (P <0.001). When compared with vehicle, terutroban was also effective in preventing cell proliferation in the media, as indicated by the reduced number of bromodeoxyuridine-positive (P <0.0001) and proliferating cell nuclear antigen-positive cells (P <0.0001). Severe fibrosis characterized by a significant accumulation of collagen and fibronectin in the vascular wall was observed in the vehicle-treated rats (P <0.01) but was completely prevented by terutroban (P <0.001). The latter also inhibited heat shock protein-47 (P <0.01) and TGF-1β expression (P <0.001), which were significantly increased by the high-salt diet. In conclusion, terutroban prevents the development of aorta hyperplasia and has beneficial effects on fibrotic processes by affecting TGF-β and heat shock protein-47 expression in SHRSPs. These findings provide mechanistic data supporting the beneficial effects of terutroban in preventing or retarding atherogenesis.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume300
Issue number3
DOIs
Publication statusPublished - Mar 2011

Fingerprint

terutroban
Thromboxanes
Hypertrophy
Blood Vessels
Fibrosis
HSP47 Heat-Shock Proteins
Diet
Aorta
Stroke
Bromodeoxyuridine
Atherosclerosis
Salts
Isoprostanes
Cerebrovascular Disorders
Eicosanoids
Proliferating Cell Nuclear Antigen
prostaglandin endoperoxide receptor
Vascular Diseases
Fibronectins
varespladib methyl

Keywords

  • Aorta
  • Stroke-prone rats

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis. / Gelosa, Paolo; Sevin, Gulnur; Pignieri, Alice; Budelli, Silvia; Castiglioni, Laura; Blanc-Guillemaud, Vanessa; Lerond, Laurence; Tremoli, Elena; Sironi, Luigi.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 300, No. 3, 03.2011.

Research output: Contribution to journalArticle

@article{bcea9550f5064e0cb833974b96de4464,
title = "Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis",
abstract = "Thromboxane A 2 and other eicosanoids such as isoprostanes contribute to vascular proliferation and atherosclerosis by binding to the thromboxane/prostaglandin endoperoxide receptors. The effects of terutroban, a thromboxane/ prostaglandin endoperoxide receptor antagonist, on aorta remodeling were evaluated in spontaneously hypertensive stroke-prone rats (SHRSPs), a model of severe hypertension, endothelial dysfunction, vascular inflammation, and cerebrovascular diseases. Male SHRSPs were allocated to three groups receiving a standard diet (n = 5) or a high-sodium permissive diet plus vehicle (n = 6) or plus terutroban (30 mg·kg -1·day -1; n = 6). After 6 wk of dietary treatment, all of the animals were injected with bromodeoxyuridine and simultaneously euthanized for aorta collection. The aortic media thickness-to-lumen ratio significantly (P <0.0001) increased in the salt-loaded rats compared with the rats fed a standard diet, whereas terutroban treatment completely prevented media thickening (P <0.001). When compared with vehicle, terutroban was also effective in preventing cell proliferation in the media, as indicated by the reduced number of bromodeoxyuridine-positive (P <0.0001) and proliferating cell nuclear antigen-positive cells (P <0.0001). Severe fibrosis characterized by a significant accumulation of collagen and fibronectin in the vascular wall was observed in the vehicle-treated rats (P <0.01) but was completely prevented by terutroban (P <0.001). The latter also inhibited heat shock protein-47 (P <0.01) and TGF-1β expression (P <0.001), which were significantly increased by the high-salt diet. In conclusion, terutroban prevents the development of aorta hyperplasia and has beneficial effects on fibrotic processes by affecting TGF-β and heat shock protein-47 expression in SHRSPs. These findings provide mechanistic data supporting the beneficial effects of terutroban in preventing or retarding atherogenesis.",
keywords = "Aorta, Stroke-prone rats",
author = "Paolo Gelosa and Gulnur Sevin and Alice Pignieri and Silvia Budelli and Laura Castiglioni and Vanessa Blanc-Guillemaud and Laurence Lerond and Elena Tremoli and Luigi Sironi",
year = "2011",
month = "3",
doi = "10.1152/ajpheart.00880.2010",
language = "English",
volume = "300",
journal = "American Journal of Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Terutroban, a thromboxane/prostaglandin endoperoxide receptor antagonist, prevents hypertensive vascular hypertrophy and fibrosis

AU - Gelosa, Paolo

AU - Sevin, Gulnur

AU - Pignieri, Alice

AU - Budelli, Silvia

AU - Castiglioni, Laura

AU - Blanc-Guillemaud, Vanessa

AU - Lerond, Laurence

AU - Tremoli, Elena

AU - Sironi, Luigi

PY - 2011/3

Y1 - 2011/3

N2 - Thromboxane A 2 and other eicosanoids such as isoprostanes contribute to vascular proliferation and atherosclerosis by binding to the thromboxane/prostaglandin endoperoxide receptors. The effects of terutroban, a thromboxane/ prostaglandin endoperoxide receptor antagonist, on aorta remodeling were evaluated in spontaneously hypertensive stroke-prone rats (SHRSPs), a model of severe hypertension, endothelial dysfunction, vascular inflammation, and cerebrovascular diseases. Male SHRSPs were allocated to three groups receiving a standard diet (n = 5) or a high-sodium permissive diet plus vehicle (n = 6) or plus terutroban (30 mg·kg -1·day -1; n = 6). After 6 wk of dietary treatment, all of the animals were injected with bromodeoxyuridine and simultaneously euthanized for aorta collection. The aortic media thickness-to-lumen ratio significantly (P <0.0001) increased in the salt-loaded rats compared with the rats fed a standard diet, whereas terutroban treatment completely prevented media thickening (P <0.001). When compared with vehicle, terutroban was also effective in preventing cell proliferation in the media, as indicated by the reduced number of bromodeoxyuridine-positive (P <0.0001) and proliferating cell nuclear antigen-positive cells (P <0.0001). Severe fibrosis characterized by a significant accumulation of collagen and fibronectin in the vascular wall was observed in the vehicle-treated rats (P <0.01) but was completely prevented by terutroban (P <0.001). The latter also inhibited heat shock protein-47 (P <0.01) and TGF-1β expression (P <0.001), which were significantly increased by the high-salt diet. In conclusion, terutroban prevents the development of aorta hyperplasia and has beneficial effects on fibrotic processes by affecting TGF-β and heat shock protein-47 expression in SHRSPs. These findings provide mechanistic data supporting the beneficial effects of terutroban in preventing or retarding atherogenesis.

AB - Thromboxane A 2 and other eicosanoids such as isoprostanes contribute to vascular proliferation and atherosclerosis by binding to the thromboxane/prostaglandin endoperoxide receptors. The effects of terutroban, a thromboxane/ prostaglandin endoperoxide receptor antagonist, on aorta remodeling were evaluated in spontaneously hypertensive stroke-prone rats (SHRSPs), a model of severe hypertension, endothelial dysfunction, vascular inflammation, and cerebrovascular diseases. Male SHRSPs were allocated to three groups receiving a standard diet (n = 5) or a high-sodium permissive diet plus vehicle (n = 6) or plus terutroban (30 mg·kg -1·day -1; n = 6). After 6 wk of dietary treatment, all of the animals were injected with bromodeoxyuridine and simultaneously euthanized for aorta collection. The aortic media thickness-to-lumen ratio significantly (P <0.0001) increased in the salt-loaded rats compared with the rats fed a standard diet, whereas terutroban treatment completely prevented media thickening (P <0.001). When compared with vehicle, terutroban was also effective in preventing cell proliferation in the media, as indicated by the reduced number of bromodeoxyuridine-positive (P <0.0001) and proliferating cell nuclear antigen-positive cells (P <0.0001). Severe fibrosis characterized by a significant accumulation of collagen and fibronectin in the vascular wall was observed in the vehicle-treated rats (P <0.01) but was completely prevented by terutroban (P <0.001). The latter also inhibited heat shock protein-47 (P <0.01) and TGF-1β expression (P <0.001), which were significantly increased by the high-salt diet. In conclusion, terutroban prevents the development of aorta hyperplasia and has beneficial effects on fibrotic processes by affecting TGF-β and heat shock protein-47 expression in SHRSPs. These findings provide mechanistic data supporting the beneficial effects of terutroban in preventing or retarding atherogenesis.

KW - Aorta

KW - Stroke-prone rats

UR - http://www.scopus.com/inward/record.url?scp=79955074227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955074227&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00880.2010

DO - 10.1152/ajpheart.00880.2010

M3 - Article

VL - 300

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6119

IS - 3

ER -